Miguel Zugman acknowledges LBP allow to modulate the gut microbiome in a more specific and scalable way
Some potential benefits of combining CBM588 plus medical treatments for cancer cell carcinoma (some benefits are microbiome independent)
#GMFH2026
Miguel Zugman updates new findings of a LBP to boost response to immune checkpoint inhibitors in metastatic renal cell carcinoma
#GMFH2026
The Oncobiome project aims to develop usable biomarkers, tests and therapeutic interventions in cancer
Lisa Dorota highlights taking antibiotics before immunitherapy may affect survival
#GMFH2026
Resistance to immune checkpoint inhibitors is common
Gianluca Ianiro us with promising findings of fecal microbiota transfers in patients without good prognosis
#GMFH2026
Simon Mark Dahl Baunwall shares clinical trials of FMT for IBS have been largely negative and unconclusive
The heterogeneity of patients with IBS can explain these findings, with superdonors providing clues on efficacy
#GMFH2026
Simon Mark Dahl Baunwall updates milestones and pitfalls on fecal microbiota transfers in UC
More questions than answers
#GMFH2026
What’s new and relevant on the gut microbiota as a potential unifying factor underlying IBS pathophysiology and symptoms?
Purna Kashyap summarizes potential mechanisms by which the gut microbiota can shape GI physiology
#GMFH2026
What if single bacterial strains can help managing C. difficile infection without the variability associated with fecal transplants?
@drnicholasbenech shares new findings on F. prausnitzii EXL01 from the LIVEDIFF phase 1 study
#GMFH2026
Take-home messages from Max Nieuwdorp on next-generation microbiome derived products for MASLD/MASH
#GMFH2026
Nieuwdorp: Liver function shapes gut microbiota-derived metabolites (endogenous ethanol) that affects NAFLD-NASH status
#GMFH2026
We’re ready for the second day of #GMFH2026!
Stay tuned to what’s new in gut microbiome precision therapeutics for metabolic syndrome, IBS and cancer
Which diet advice works and doesn’t work for IBS?
Miranda Lomer @kingscollegelondon.bsky.social updates the evidence based on systematic reviews
#GMFH2026
Now Wendy Garrett at #GMFH2026 presenting 6 years of work showing how some dietary sulfur-containing amino acids can drive Mucispirillum expansion and initiate an immune cascade leading to CD8 T cell activation.
Beautiful mechanistic work. Always a Big fan of Garrett Lab @gmfhx.bsky.social
Beyond gut bacteria, viruses can have a role in IBS pathogenesis and relate to some dietary items
Some gut microbiome signals may have implications for explaining the response to diets for IBS
@MagnusSimren
#GMFH2026
Take-aways from @richardhansen.bsky.social on what to tell healthy first-degree relatives and those at risk of IBD
#GMFH2026
Magnus Simrén updates the prevalence of sub-diagnostic GI symptoms across the globe
Subjects with subdiagnostic GI symptoms are increasingly common and have a poor food-related quality of life
#GMFH2026
Another great talk : NSegata @cibiocm.bsky.social
at #GMFH2026: our gut microbiome is built from microbes around us the ones we eat (e.g. fermented foods), partners, pets, and our environment.
A reminder that microbiome interventions should consider these microbial inputs. @gmfhx.bsky.social
Dietary interventions in different cohorts showed consistent microbial signatures
Nicola Segata @cibiocm.bsky.social #GMFH2026
There are no single dietary intervention that works for two identical twins
Nicola segata acknowledges the multiple variables beyond microbiome accounting for that @cibiocm.bsky.social
#GMFH2026
Now refreshing talk from @fasnicar.bsky.social at #GMFH2026 presenting data suggesting Blastocystis may be a marker of good diet and health. Higher abundance associates with better health. Quite thought-provoking given it’s often targeted for eradication in IBS or in FMT @gmfhx.bsky.social
Take-home messages from @fasnicar.bsky.social on the role of Blastocystis on metabolic health and the importance to consider interactions between gut microbiome members
#GMFH2026
Great talk by @jenswalter15.bsky.social at #GMFH2026 showing that fiber intake well beyond current recommendations (>35 g/day) could bring major health benefits. The real challenge? Adherence. The NiMe™ diet or fiber-fortified foods may help close the gap. @gmfhx.bsky.social
Take-home messages from @jenswalter15.bsky.social on nuances in dietary fiber recommendation and examples of research translation from bench to plate
#GMFH2026
A non-industrialized diet can restore the impact of industrialization on cardiometabolic risk markers through the gut microbiome and intestinal pH
@jenswalter15.bsky.social
#GMFH2026
Eran Segal (remotely) at #GMFH2026 showcasing how deep phenotyping + AI foundation models can predict future health — and responses to interventions. Fascinating ! Paving the way for the future of digital / precision medicine. @GMFHx
Can we use phenotypic and smartwatch-driven data for driving better health outcomes?
@segal_eran presents new findings on the Human Phenotype Project based on natural language
#GMFH2026
Algorithm-based personalized nutrition that integrates the microbiome show a good capacity to predict metabolic outcomes @segal_eran
#GMFH2026
Now @drharmstrong.bsky.social #GMFH2026 showing that purified fibers (beta-fructans) — or even high-fiber diets — may have negative effects in certain contexts (IBD, MS..), bc altered microbiomes ? Or purified fiber?
Another thought-provoking talk challenging old concepts. @gmfhx.bsky.social
Using nutrition in clinical populations should take into account the gut microbiome
@drharmstrong.bsky.social is working on a microbiome and AI-based methodology to tailor carbohydrate intake and provide non-restrictive diet advice #GMFH2026
